Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators (Q73096135)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1

P E Marik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

J Iglesias

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

387-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

Acute renal failure in intensive care units--causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure.

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Acute Renal Failure in the Medical Intensive Care Unit: Predisposing, Complicating Factors and Outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Is renal dose dopamine protective or therapeutic? No.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Use of dopamine in the ICU. Hope, hype, belief and facts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

"Renal dose" dopamine in surgical patients: dogma or science?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Renal-dose dopamine: fact and fiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Renal-dose dopamine: a siren song?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Renal effects of dopamine: can our dream ever come true?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Dopamine-1 and dopamine-2 mechanisms in the control of renal function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Different mechanisms of renal Na-K-ATPase regulation by dopamine in the proximal and distal nephron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Dopamine causes stimulation of protein kinase C in rat renal proximal tubules by activating dopamine D1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Dopamine, dobutamine, and dopexamine. A comparison of renal effects in unanesthetized human volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

DIRECT RENAL VASODILATATION PRODUCED BY DOPAMINE IN THE DOG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Dopaminergic inhibition of the action of vasopressin on the cortical collecting tubule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Dopamine administration in oliguria and oliguric renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Synergism of dopamine and furosemide in diuretic-resistant, oliguric acute renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Dopamine and frusemide in oliguric acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Furosemide and dopamine in malarial acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Altered renal homeostasis with acute sepsis. Clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Prerenal failure: a deleterious shift from renal compensation to decompensation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Sepsis-associated renal vasoconstriction: potential targets for future therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Renal vasculature and ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Dopamine and the kidney: ten years on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

Renovascular interaction of epinephrine, dopamine, and intraperitoneal sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900246-6

10.1016/S0002-9343(99)00246-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10527041%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference